Industry Educational Session - Navigating the changing landscape in diffuse large B-cell lymphoma (Gilead products will be discussed in this symposium) - Sponsored by Gilead
Tracks
Track 3
| Monday, April 29, 2024 |
| 11:10 AM - 11:40 AM |
| Room 3A |
Details
Learning objectives:
• Review recent changes in DLBCL treatment in the first, second, and third lines
• Understand the evidence on optimal treatment sequencing in DLBCL
• Discuss practical changes needed to implement treatments in the evolving DLBCL landscape
Speaker
Prof. John Gribben
Professor of Medical Oncology
Barts and The London School of Medicine, Queen Mary University of London
-
Dr. Wendy Osborne
Consultant Haematologist
Freeman Hospital Newcastle
-
